Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythromelalgia.

Peter Franz Klein-Weigel1, Theresa Sophie Volz1, Jutta Gisela Richter2

  • 11 Klinik für Angiologie, Helios Klinik Berlin-Buch, Berlin, Germany.

VASA. Zeitschrift Fur Gefasskrankheiten
|January 5, 2018
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular manifestations of thalidomide embryopathy.

VASA. Zeitschrift fur Gefasskrankheiten·2025
Same author

Inferior vena cava-syndrome.

VASA. Zeitschrift fur Gefasskrankheiten·2021
Same author

Superior vena cava syndrome.

VASA. Zeitschrift fur Gefasskrankheiten·2020
Same author

Buerger's disease: providing integrated care.

Journal of multidisciplinary healthcare·2016
Same author

Nailfold capillaroscopy microscopy - an interdisciplinary appraisal.

VASA. Zeitschrift fur Gefasskrankheiten·2016
Same author

[Thromboangiitis obliterans (Buerger's disease): update 2015].

Deutsche medizinische Wochenschrift (1946)·2015
Same journal

A new era in carotid prevention - critical appraisal of the CREST-2 results.

VASA. Zeitschrift fur Gefasskrankheiten·2026
Same journal

Management of venous thromboembolism in France - a nationwide clinical practice survey among vascular medicine specialists.

VASA. Zeitschrift fur Gefasskrankheiten·2026
Same journal

Endovascular salvage of distal infrainguinal bypass anastomotic stenosis following thrombectomy using a heparin-bonded covered stent.

VASA. Zeitschrift fur Gefasskrankheiten·2026
Same journal

Optimal ablation length for effective treatment of great saphenous vein insufficiency.

VASA. Zeitschrift fur Gefasskrankheiten·2026
Same journal

Long-term outcomes of covered versus bare metal stents in the reconstruction of the aortic bifurcation.

VASA. Zeitschrift fur Gefasskrankheiten·2026
Same journal

Early discharge and home treatment after acute pulmonary embolism.

VASA. Zeitschrift fur Gefasskrankheiten·2026
See all related articles

Erythromelalgia causes severe pain in extremities due to genetic or secondary causes affecting sodium channels. Treatment focuses on pain relief and improving quality of life.

Area of Science:

  • Neurology
  • Genetics
  • Dermatology

Background:

  • Erythromelalgia is a rare condition causing severe pain and redness in extremities.
  • Primary erythromelalgia is linked to genetic mutations in sodium channel genes (SCN9A, SCN10A, SCN11A).
  • Secondary erythromelalgia can be associated with various medical conditions.

Purpose of the Study:

  • To provide a comprehensive overview of erythromelalgia.
  • To discuss diagnostic criteria and differentiation between primary and secondary forms.
  • To outline therapeutic strategies and prognostic factors.

Main Methods:

  • Clinical feature assessment for diagnosis.
  • Genetic testing for primary erythromelalgia, especially in familial cases.
  • Review of non-pharmacological and pharmacological treatment options.
Keywords:
Erythromelalgiachronic pain syndrome small fibre polyneuropathy.erythermalgiagenetic pain syndromevascular acrosyndrome

Related Experiment Videos

Main Results:

  • Diagnosis relies on characteristic clinical presentation.
  • Genetic testing is crucial for identifying primary erythromelalgia.
  • Multimodal treatment approaches are individualized for pain management.

Conclusions:

  • Accurate diagnosis and differentiation are key.
  • Genetic counseling and testing are recommended for primary forms.
  • Therapeutic interventions aim to improve patient quality of life.